Detalhe da pesquisa
1.
Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults.
Blood
; 129(25): 3322-3331, 2017 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28408462
2.
Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases.
Mol Ther
; 24(3): 570-81, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26502778
3.
Tumors induce coordinate growth of artery, vein, and lymphatic vessel triads.
BMC Cancer
; 14: 354, 2014 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24886322
4.
Identification of protective and 'at risk' HLA genotypes for the development of pseudotumours around metal-on-metal hip resurfacings.
Bone Jt Open
; 4(3): 182-187, 2023 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37051827
5.
Mapping tissue-specific expression of extracellular proteins using systematic glycoproteomic analysis of different mouse tissues.
J Proteome Res
; 9(11): 5837-47, 2010 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20828161
6.
Tumor suppression by p53 in the absence of Atm.
Mol Cancer Res
; 6(7): 1185-92, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18583527
7.
Identification of glycoproteins from mouse skin tumors and plasma.
Clin Proteomics
; 4(3-4): 117-136, 2008 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21072318
8.
Differential Plasma Glycoproteome of p19 Skin Cancer Mouse Model Using the Corra Label-Free LC-MS Proteomics Platform.
Clin Proteomics
; 4(3-4): 105, 2008 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20157627
9.
p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.
PLoS Biol
; 2(8): E242, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15314658
10.
Functional Tuning of CARs Reveals Signaling Threshold above Which CD8+ CTL Antitumor Potency Is Attenuated due to Cell Fas-FasL-Dependent AICD.
Cancer Immunol Res
; 3(4): 368-79, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25576337
11.
Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression.
Cancer Res
; 71(15): 5090-100, 2011 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21653680
12.
Plasma proteome profiles associated with inflammation, angiogenesis, and cancer.
PLoS One
; 6(5): e19721, 2011 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-21589862
13.
Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.
Cancer Cell
; 20(3): 289-99, 2011 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-21907921
14.
A targeted proteomics-based pipeline for verification of biomarkers in plasma.
Nat Biotechnol
; 29(7): 625-34, 2011 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-21685906
15.
Proteome and transcriptome profiles of a Her2/Neu-driven mouse model of breast cancer.
Proteomics Clin Appl
; 5(3-4): 179-88, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21448875
16.
A mouse model repository for cancer biomarker discovery.
J Proteome Res
; 7(8): 3613-8, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18624399
17.
Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.
J Proteome Res
; 7(4): 1481-9, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18311905
18.
Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.
J Proteome Res
; 6(10): 3962-75, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17711321
19.
A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression.
Genes Dev
; 20(1): 47-64, 2006 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16391232
20.
High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry.
Mol Cell Proteomics
; 4(2): 144-55, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15608340